We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
HubSpot
HUBS
$12.5B
| $39M | 0.1% |
+73,329
| New | +$34.4M |
|
|
CERE
252
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $38.6M | 0.1% |
1,214,972
-710,000
| -37% | -$21.8M |
|
253
Walmart Inc
WMT
$865B
| $38.6M | 0.1% |
735,798
-132,186
| -15% | -$6.67M |
|
254
Ecolab
ECL
$77.2B
| $38.5M | 0.1% |
206,062
-89,872
| -30% | -$15.5M |
|
255
Lamar Advertising Co
LAMR
$15.1B
| $38.4M | 0.1% |
386,963
-30,362
| -7% | -$2.95M |
|
256
UGI
UGI
$8.09B
| $38.3M | 0.1% |
1,420,777
+108,291
| +8% | +$3.29M |
|
257
American Water Works
AWK
$27.4B
| $38.1M | 0.09% |
267,065
-24,388
| -8% | -$3.58M |
|
258
Pegasystems
PEGA
$5.96B
| $38M | 0.09% |
1,540,242
-200,118
| -11% | -$4.65M |
|
259
Artisan Partners
APAM
$2.69B
| $37.9M | 0.09% |
963,174
+38,174
| +4% | +$1.32M |
|
260
United Airlines
UAL
$35.4B
| $37.7M | 0.09% |
687,686
+14,382
| +2% | +$679K |
|
261
M&T Bank
MTB
$34.6B
| $37.4M | 0.09% |
302,045
+72,443
| +32% | +$8.76M |
|
262
TSMC
TSM
$2.17T
| $36.8M | 0.09% |
364,961
+29,669
| +9% | +$2.76M |
|
263
Caterpillar
CAT
$360B
| $36.8M | 0.09% |
149,635
-17,523
| -10% | -$3.91M |
|
264
Mastercard
MA
$503B
| $36.4M | 0.09% |
92,546
-2,240
| -2% | -$841K |
|
265
Green Dot
GDOT
$756M
| $36.1M | 0.09% |
1,928,678
+115,763
| +6% | +$2.05M |
|
266
Ulta Beauty
ULTA
$23.5B
| $36M | 0.09% |
76,485
-12,536
| -14% | -$6.14M |
|
|
RPC
267
Ridgepost Capital
RPC
$894M
| $36M | 0.09% |
3,181,933
| – | – |
|
268
Home Depot
HD
$308B
| $35.7M | 0.09% |
114,882
-35,530
| -24% | -$10.5M |
|
|
VRNA
269
DELISTED
Verona Pharma
VRNA
| $35.3M | 0.09% |
1,670,698
+1,268,648
| +316% | +$27.1M |
|
270
Ingersoll Rand
IR
$28.3B
| $35.3M | 0.09% |
539,926
+7,603
| +1% | +$450K |
|
271
Okta
OKTA
$32.6B
| $35.1M | 0.09% |
506,574
-217,264
| -30% | -$16.5M |
|
272
e.l.f. Beauty
ELF
$5.71B
| $35.1M | 0.09% |
307,475
-85,476
| -22% | -$8.23M |
|
273
Yeti Holdings
YETI
$2.94B
| $34.8M | 0.09% |
894,796
-43,135
| -5% | -$1.67M |
|
|
HCP
274
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $34.5M | 0.09% |
+1,317,400
| New | +$38.6M |
|
275
Hartford Financial Services
HIG
$36.9B
| $34.2M | 0.09% |
475,491
-23,626
| -5% | -$1.66M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.